RGBOQ — ReGen Biologics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for ReGen Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.2 | -11.7 | -12.7 | -10.4 | -9.95 |
| Depreciation | |||||
| Non-Cash Items | 0.662 | 0.603 | 1.22 | 1.46 | 2.15 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.374 | 1.36 | -0.865 | -0.332 | 0.921 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.11 | -9.72 | -12.2 | -9.16 | -6.78 |
| Capital Expenditures | -0.019 | -0.125 | -0.182 | -0.171 | -0.029 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -4 | 3.35 | 0.548 | 0.1 |
| Change in Net Investments | |||||
| Cash from Investing Activities | -0.019 | -4.12 | 3.17 | 0.377 | 0.071 |
| Financing Cash Flow Items | — | — | — | 0 | -0.128 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10 | 11.2 | 6.84 | 5.55 | 2.89 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.87 | -2.65 | -2.27 | -3.26 | -3.76 |